We are joined by Alan Parsa to discuss the most important advances in the use of ultrasound to assess thyroid nodules and the benefits of this technique in determining malignancy risk.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA.
Questions:
1. What are the most important ultrasonographic features for determining the malignancy risk of thyroid nodules? (0:05)
2. How are the major endocrinology societies similar in their classification of malignancy risk of thyroid nodules? (1:21)
3. What are the advantages of the Bethesda System of classification of thyroid nodules? (3:28)
4. What are the benefits of using ultrasound-guided fine needle aspiration for determining malignancy risk? (05:20)
Alan Parsa has no conflicts of interest to declare in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
